Encompass Health Corp (EHC) Stock Price & Analysis

Encompass Health Corp (EHC) fell 0.65% to USD 121.79 as of September 8, 2026 at 05:01 UTC, according to Nexqual real-time market data.

EHC last closed at USD 121.79; the session ranged USD 121.65–122.62 on volume of 507,474 shares. Market capitalization is —, with a 52-week range of USD 92.77–127.99 (NYQ). Source: Nexqual, September 8, 2026 at 05:01 UTC.

Key Statistics (as of September 8, 2026 at 05:01 UTC)

Technical Analysis (EHC)

Nexqual's technical model rates EHC "BUY" based on 4 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 05:01 UTC.

Leadership (EHC)

Encompass Health Corp is led by Mark J. Tarr (age 63), CEO, President & Director, per Nexqual as of September 8, 2026 at 05:01 UTC.

Major Backers & Investors (EHC)

Notable institutional backers of Encompass Health Corp include Price (T.Rowe) Associates Inc, Wellington Management, Citadel, according to Nexqual as of September 8, 2026 at 05:01 UTC.

Active Investors

Index Funds (Passive)

Source: Nexqual, September 8, 2026 at 05:01 UTC.

From Encompass Health Corp's Latest SEC 10-K Filing (filed 2026-02-26)

Key Strengths & Strategy (as disclosed to the SEC)

• We will continue to develop and implement post-acute solutions that allow us to apply our clinical expertise, large post-acute datasets, electronic medical record technologies, and strategic partnerships to drive improved patient outcomes and lower the cost of care across the entire post-acute episode.
• We believe our consistent and disciplined operating model allows us to be nimble and responsive to change as we have shown following a number of significant changes to our Medicare payment system. • Strategic Relationships .
• The post-acute innovation tools we have developed, and will continue to develop, support our strategic relationship initiatives by enhancing the effective and efficient management of patients across multiple post-acute care settings and facilitating high-quality patient care, improved care coordination, and network provider performance and cost management.
• We have extensive clinical experience from which we have developed standardized best practices and protocols.

Partnerships

• For de novo hospitals, we utilize a centralized and repeatable talent attraction and hiring process, including coordinated marketing across multiple digital media channels and close collaboration with hospital leadership teams.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:01 UTC. This page is informational and not investment advice.